跳至主要内容
临床试验/NL-OMON49864
NL-OMON49864已完成不适用

Identification of sentinel lymph nodes in breast cancer patients through non-invasively and percutaneously fluorescent imaging using ICG - INFLUENCE-trial

Sint Antonius Ziekenhuis0 个研究点目标入组 102 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
102

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Clinically node-negative, invasive early T1 or T2 breast cancer confirmed by
  • - Preoperative axillary ultrasound to confirm clinical node-negative status.
  • - Indication for lumpectomy and SLN procedure.
  • - Written informed consent according to ICH/GCP and national regulations.

排除标准

  • - Patients < 18 years old.
  • - Mastectomy.
  • - Known allergy for indocyanine green (ICG) or radioisotope technetium (99mTc)
  • or intravenous contrast, iodine, shellfish.
  • - Other concurrent solid tumor.
  • - Hyperthyroidism or thyroid cancer.
  • - Palliative surgery for locally advanced breast cancer (cT4).
  • - Pregnancy or breast feeding.
  • - Psychological, familial, sociological or geographical factors that could
  • potentially hamper compliance with the study protocol.

研究者

相似试验